INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
HOUSE PTR/SaleVerified data

Mike Kelly sold BMY

Spouse · BRISTOL MYERS SQUIBB CO · Bristol-Myers Squibb Company Common Stock

Side
SELL
Value range
$15K – $50K
Shares
Not disclosed
Price
—
Executed
May 7, 2026
Disclosed
Jun 11, 2026
Disclosure timeline35 days from execution to publication · legal deadline 45 days
May 7 executedJun 11, 2026 disclosed

BMY · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
28/ 100 · ROUTINE
Methodology →
  • Transaction type+10 / 20

    Sale

  • Relative size+6 / 25

    Disclosed range starting at $15K

  • Filing timing+4 / 15

    Disclosed 35 days after execution (STOCK Act deadline: 45)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · BMY

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    21
    LA
    Lenkowsky AdamEVP, Chief Commercial Officer
    BMYBRISTOL MYERS SQUIBB CO
    Option exercise
    M—
    7,522 sh
    Nov 3, 2026Nov 4, 2026
    traded Nov 3, 2026
    +1dSEC FORM 4

    Evidence

    17
    LA
    Lenkowsky AdamEVP, Chief Commercial Officer
    BMYBRISTOL MYERS SQUIBB CO
    Option exercise
    M—
    7,522 sh
    Nov 3, 2026Nov 4, 2026
    traded Nov 3, 2026
    +1dSEC FORM 4

    Evidence

    16
    LA
    Lenkowsky AdamEVP, Chief Commercial Officer
    BMYBRISTOL MYERS SQUIBB CO
    Tax withholding
    F$237K
    3,848 sh
    Nov 3, 2026Nov 4, 2026
    traded Nov 3, 2026
    +1dSEC FORM 4

    Evidence

    17
    SK
    Shanahan KarinEVP, Chief Supply Chain & Ops
    BMYBRISTOL MYERS SQUIBB CO
    Option exercise
    M—
    6,281 sh
    Nov 1, 2026Nov 3, 2026
    traded Nov 1, 2026
    +2dSEC FORM 4

    Evidence

    9
    SK
    Shanahan KarinEVP, Chief Supply Chain & Ops
    BMYBRISTOL MYERS SQUIBB CO
    Option exercise
    M—
    6,281 sh
    Nov 1, 2026Nov 3, 2026
    traded Nov 1, 2026
    +2dSEC FORM 4

    Evidence

    16
    MS
    Meyers Gregory ScottEVP, Chief Digital & Tech Off.
    BMYBRISTOL MYERS SQUIBB CO
    Tax withholding
    F$167K
    2,665 sh
    Nov 1, 2026Nov 3, 2026
    traded Nov 1, 2026
    +2dSEC FORM 4

    Evidence

    16
    SK
    Shanahan KarinEVP, Chief Supply Chain & Ops
    BMYBRISTOL MYERS SQUIBB CO
    Tax withholding
    F$201K
    3,213 sh
    Nov 1, 2026Nov 3, 2026
    traded Nov 1, 2026
    +2dSEC FORM 4

    Evidence

    17
    MS
    Meyers Gregory ScottEVP, Chief Digital & Tech Off.
    BMYBRISTOL MYERS SQUIBB CO
    Option exercise
    M—
    6,281 sh
    Nov 1, 2026Nov 3, 2026
    traded Nov 1, 2026
    +2dSEC FORM 4

    Evidence

    9
    MS
    Meyers Gregory ScottEVP, Chief Digital & Tech Off.
    BMYBRISTOL MYERS SQUIBB CO
    Option exercise
    M—
    6,281 sh
    Nov 1, 2026Nov 3, 2026
    traded Nov 1, 2026
    +2dSEC FORM 4

    Evidence

    16
    GC
    Gallman CariEVP, General Counsel
    BMYBRISTOL MYERS SQUIBB CO
    Tax withholding
    F$143K
    2,332 sh
    Oct 2, 2026Oct 5, 2026
    traded Oct 2, 2026
    +3dSEC FORM 4

    Evidence

    17
    GC
    Gallman CariEVP, General Counsel
    BMYBRISTOL MYERS SQUIBB CO
    Option exercise
    M—
    4,559 sh
    Oct 2, 2026Oct 5, 2026
    traded Oct 2, 2026
    +3dSEC FORM 4

    Evidence

    9
    GC
    Gallman CariEVP, General Counsel
    BMYBRISTOL MYERS SQUIBB CO
    Option exercise
    M—
    4,559 sh
    Oct 2, 2026Oct 5, 2026
    traded Oct 2, 2026
    +3dSEC FORM 4

    Evidence

    35
    MC
    Massacesi CristianEVP,Chief Med Offr,Head of Dev
    BMYBRISTOL MYERS SQUIBB CO
    Open-market sale
    SELL$403K
    6,249 sh
    Sep 9, 2026Sep 10, 2026
    traded Sep 9, 2026
    +1dSEC FORM 4

    Evidence

    9
    SW
    Short Bartie WendyEVP, Corporate Affairs
    BMYBRISTOL MYERS SQUIBB CO
    Option exercise
    M—
    1,236 sh
    Sep 1, 2026Sep 3, 2026
    traded Sep 1, 2026
    +2dSEC FORM 4

    Evidence

    13
    SW
    Short Bartie WendyEVP, Corporate Affairs
    BMYBRISTOL MYERS SQUIBB CO
    Tax withholding
    F$42K
    633 sh
    Sep 1, 2026Sep 3, 2026
    traded Sep 1, 2026
    +2dSEC FORM 4

    Evidence

    16
    SW
    Short Bartie WendyEVP, Corporate Affairs
    BMYBRISTOL MYERS SQUIBB CO
    Option exercise
    M$83K
    1,236 sh
    Sep 1, 2026Sep 3, 2026
    traded Sep 1, 2026
    +2dSEC FORM 4

    Evidence

    21
    HM
    Holzer Phil MSVP and Controller
    BMYBRISTOL MYERS SQUIBB CO
    Open-market sale
    SELL$34K
    500 sh
    Aug 25, 2026Aug 26, 2026
    traded Aug 25, 2026
    +1dSEC FORM 4

    Evidence

    9
    SW
    Short Bartie WendyEVP, Corporate Affairs
    BMYBRISTOL MYERS SQUIBB CO
    Option exercise
    M—
    8,040 sh
    Jun 3, 2026Jun 5, 2026
    traded Jun 3, 2026
    +2dSEC FORM 4

    Evidence

    20
    SW
    Short Bartie WendyEVP, Corporate Affairs
    BMYBRISTOL MYERS SQUIBB CO
    Tax withholding
    F$212K
    3,876 sh
    Jun 3, 2026Jun 5, 2026
    traded Jun 3, 2026
    +2dSEC FORM 4

    Evidence

    21
    SW
    Short Bartie WendyEVP, Corporate Affairs
    BMYBRISTOL MYERS SQUIBB CO
    Option exercise
    M—
    8,040 sh
    Jun 3, 2026Jun 5, 2026
    traded Jun 3, 2026
    +2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    House Periodic Transaction Report
    Publisher
    Clerk of the U.S. House of Representatives
    Document ID
    20034767

    Timestamps

    Event (reported)
    May 7, 2026
    Published
    Jun 11, 2026
    Ingested by INSIDER
    Nov 5, 00:34 UTC
    Last re-read
    Nov 5, 06:47 UTC

    Extracted facts

    Filer
    Mike Kelly
    Role
    SpouseAs filed: “SP”
    Transaction
    SaleAs filed: “S”
    Asset
    Bristol-Myers Squibb Company Common Stock
    Ticker
    BMY
    Reported value
    $15K – $50KAs filed: “$15,001 - $50,000”
    Execution date (reported)
    May 7, 2026
    Notification date (reported)
    Jun 10, 2026
    Days from execution to publication
    35

    Calculation

    Midpoint = (low + high) / 2. Used only to rank and sum ranges; the true value can be anywhere in the range.

    • Low: $15,001
    • High: $50,000

    = $32,501

    What this establishes

    Mike Kelly reported a sale of Bristol-Myers Squibb Company Common Stock (owner: spouse). Members report a value range, not an exact amount, and do not report share counts or prices. Dates are as entered by the filer. A trade report is not evidence of wrongdoing.

    Extraction

    Method
    PDF text extraction
    Confidence
    1.00
    Spouse
    Mike Kellybioguide:K000376
    Issuer
    BRISTOL MYERS SQUIBB COcik:0000014272

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.